Le Lézard
Classified in: Science and technology
Subjects: NPT, TDS, FVT

(ISC)2 Announces Slate of Cybersecurity Trailblazers as Keynote Speakers for Secure Summit DC


CLEARWATER, Fla., March 13, 2018 /PRNewswire-USNewswire/ -- (ISC)² ? the world's largest nonprofit association of certified cybersecurity professionals ? today announced the keynotes for its Secure Summit DC (formerly known as CyberSecureGov) training event taking place May 7-8 at the MGM National Harbor in the DC metro area. These distinguished speakers will share expert insight into a broad array of issues facing the cybersecurity profession, ranging from evolving attack patterns to growing and sustaining the nation's cybersecurity workforce.

(ISC)² Secure Summit DC will assemble the best minds in cybersecurity for two days of insightful discussions, workshops and best-practices sharing. The goal of the event is to equip security leaders to tackle today's threats, as well as arm them with the knowledge, tools and expertise to protect their organizations and advance their careers. Registered attendees will be immersed in two days of insightful, strategic cybersecurity knowledge.

"(ISC)² Secure Summit DC will cover practical, effective response strategies that cybersecurity professionals in the public and private sectors need to learn to be successful in today's environment," said Brian Correia, managing director for North America, (ISC)². "This lineup of keynote speakers is packed with brilliant minds who will offer thought-provoking perspectives on the cybersecurity industry."

The keynote speakers for (ISC)² Secure Summit DC are:

For the lineup of keynote speakers, please visit http://www.cvent.com/events/securesummitdc/custom-39-a73abe5f2a50473fa0f143415094cbb9.aspx. Registration is open online at https://www.cvent.com/events/securesummitdc/registration-a73abe5f2a50473fa0f143415094cbb9.aspx?fqp=true.

About (ISC)²
(ISC)² is an international nonprofit membership association focused on inspiring a safe and secure cyber world. Best known for the acclaimed Certified Information Systems Security Professional (CISSP®) certification, (ISC)2 offers a portfolio of credentials that are part of a holistic, programmatic approach to security. Our membership, over 130,000 strong, is made up of certified cyber, information, software and infrastructure security professionals who are making a difference and helping to advance the industry. Our vision is supported by our commitment to educate and reach the general public through our charitable foundation ? The Center for Cyber Safety and EducationTM. For more information on (ISC)², visit www.isc2.org, follow us on Twitter or connect with us on Facebook

© 2018, (ISC)² Inc., (ISC)², CISSP, SSCP, CCSP, CAP, CSSLP, HCISPP, CCFP, CISSP-ISSAP, CISSP-ISSEP, CISSP-ISSMP and CBK are registered marks, of (ISC)², Inc.

Media Contact
Amanda Tarantino
Manager, Corporate Communications
(ISC)²
[email protected]
727-877-2230

SOURCE (ISC)2


These press releases may also interest you

at 21:30
Rubrik, Inc. today announced the pricing of its upsized initial public offering of 23,500,000 shares of its Class A common stock at a public offering price of $32.00 per share. In addition, Rubrik has granted the underwriters a 30-day option to...

at 21:27
Labcorp , a global leader of innovative and comprehensive laboratory services, announced today that it has been selected as the winning bidder for select assets of Invitae, a leading medical genetics company.  Before the transaction can proceed,...

at 21:26
OKX, a leading Web3 technology company, has issued updates for April 24, 2024. OKX DeFi Launches 'zkSwap Bonus Event' Offering Users...

at 21:19
Invitae , a leading medical genetics company, announced that Labcorp , a global leader of innovative and comprehensive laboratory services, has been selected...

at 21:05
The Board of Directors of TransAlta Corporation declared a quarterly dividend of $0.06 per common share payable on July 1, 2024 to shareholders of record at the close of business on June 1, 2024. The Board of Directors also declared the following...

at 21:02
Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancer, chronic hepatitis B (CHB), and age-related diseases, announced today that results from four clinical studies of the company's three key...



News published on and distributed by: